RedHill Biopharma Ltd.
Asset & Liabilities Breakdown
Asset Breakdown FY2024
Total Assets: $18.0M
Liabilities Breakdown FY2024
Total Liabilities: $22.7M
Asset Breakdown
Total Assets: $18.0M
| Line Item | Value | % of Total |
|---|---|---|
| Cash & Equivalents | $4.6M | 25.6% |
| Accounts Receivable | $2.5M | 14.1% |
| Inventory | $3.7M | 20.2% |
| Property, Plant & Equipment | $0 | 0.0% |
| Goodwill | $0 | 0.0% |
| Intangible Assets | $0 | 0.0% |
| Other Assets | $7.2M | 40.1% |
Liabilities Breakdown
Total Liabilities: $22.7M
| Line Item | Value | % of Total |
|---|---|---|
| Accounts Payable | $1.2M | 5.1% |
| Long-Term Debt | $0 | 0.0% |
| Other Liabilities | $21.6M | 94.9% |